Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Recruiting · NCT06190067 · Registry updated 2024-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma; Relapsed Classic Hodgkin Lymphoma | Recruiting | Phase 2 | 2024-01-30 | NCT06190067 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Navy General Hospital, Beijing | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Navy General Hospital | Beijing | China | 9 |